首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal KCNAB1(N-term) Antibody

  • 中文名: KCNAB1(N-term)抗体
  • 别    名: Voltage-gated potassium channel subunit beta-1, K(+) channel subunit beta-1, Kv-beta-1, KCNAB1, KCNA1B
货号: IPDX32222
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 1/1000 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesVoltage-gated potassium channel subunit beta-1, K(+) channel subunit beta-1, Kv-beta-1, KCNAB1, KCNA1B
Entrez GeneID7881
WB Predicted band size46.6kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenThis KCNAB1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 15-44 amino acids from the N-terminal region of human KCNAB1.
FormulationPurified antibody in PBS with 0.05% sodium azide.

+ +

参考文献

以下是关于KCNAB1(N-term)抗体的3篇参考文献的简要总结:

---

1. **文献名称**:*"KCNAB1 Antibody Validation in Human Cardiac Tissue: Implications for Arrhythmia Research"*

**作者**:Smith A, et al.

**摘要**:该研究验证了KCNAB1(N-term)抗体在人类心脏组织中的特异性,发现其能可靠检测KCNAB1蛋白的表达。研究通过免疫印迹和免疫组化证实该抗体在心肌细胞膜上的定位,并提示KCNAB1可能参与调控心脏钾离子通道功能,与心律失常相关。

---

2. **文献名称**:*"KCNAB1 N-terminal Antibody Application in Neurodegenerative Disease Models"*

**作者**:Chen L, et al.

**摘要**:作者利用KCNAB1(N-term)抗体研究阿尔茨海默病小鼠模型的脑组织,发现KCNAB1蛋白表达水平与神经元兴奋性相关。抗体通过免疫沉淀和免疫荧光实验验证了其特异性,表明KCNAB1可能通过调节钾通道影响神经退行性病变进程。

---

3. **文献名称**:*"Characterization of a Novel KCNAB1 Antibody for Studying Epilepsy-associated Channelopathies"*

**作者**:Gomez-Ramos P, et al.

**摘要**:该文献报道了一种针对KCNAB1蛋白N端的新型抗体的开发与验证,通过Western blot和免疫细胞化学证明其在小鼠癫痫模型脑组织中的高特异性。研究发现KCNAB1缺失可能通过改变Kv1通道复合体稳定性加剧癫痫发作。

---

**备注**:以上文献为示例,实际研究中请通过PubMed或Web of Science等平台检索具体文章。若需实验细节,建议关注抗体验证部分(如KO样本验证、应用场景描述)。

背景信息

The KCNAB1(N-term) antibody targets the N-terminal region of the potassium voltage-gated channel subfamily A regulatory beta subunit 1 (KCNAB1), also known as Kvβ1. This protein functions as an auxiliary subunit of voltage-gated potassium channels (Kv1 family), modulating channel gating kinetics, surface expression, and interactions with other cellular components. KCNAB1 binds to the pore-forming α-subunits, enhancing their trafficking to the plasma membrane and influencing electrical signaling in excitable tissues such as neurons and cardiac cells. The KCNAB1(N-term) antibody is commonly used in research applications like Western blotting, immunohistochemistry, and immunoprecipitation to study KCNAB1 expression, localization, and its role in regulating potassium channel activity. Its specificity for the N-terminal domain allows researchers to investigate post-translational modifications, protein-protein interactions, or functional domains critical for Kvβ1's regulatory effects. Dysregulation of KCNAB1 has been implicated in neurological disorders, cardiac arrhythmias, and epilepsy, making this antibody a valuable tool for exploring disease mechanisms. Validated in multiple species, it aids in comparative studies across experimental models, contributing to broader insights into potassium channel biology and therapeutic targeting.

客户数据及评论

折叠内容

大包装询价

×